Over-expression EGFR reduced sensitivity of human endometrial carcinoma cells to progesterone

Wang Juan,Ai Zhihong,Teng Yincheng
DOI: https://doi.org/10.13283/j.cnki.xdfckjz.2009.12.025
2009-01-01
Abstract:Objective:To examine expressions of EGFR gene in endometrial carcinoma progesterone-sensitive cell line Ishikawa cells and progesterone-resistant cell line KLE cells,and evaluate the effect of over-expression EGFR gene on progesterone sensitivity of Ishikawa cells.Methods:The expressions of EGFR,PR-B mRNA and protein in Ishikawa and KLE cells were detected by real-time PCR and Western blot.Recombinant eukaryotic expression plasmid containing human hole length cDNA of EGFR gene was transfected into Ishikawa cells by lipofectamine 2000.The expressions of EGFR,PR-B mRNA were monitored by real-time PCR and the expressions of EGFR,PR-B protein were analyzed by Western blot in EGFR transfected and untransfected Ishikawa cells.Proliferation and sensitivity of cells to progesterone were measured by Cell Counting Kit-8(CCK-8).Results:(1)The expressions of EGFR mRNA and protein in Ishikawa cells were significantly lower than those in KLE cells(P<0.001).However the expressions of PR-B mRNA and protein were converse(P<0.001).(2)After stably transfected with EGFR gene,the expressions of EGFR mRNA and protein in Ishikawa cells were higher than those in Ishikawa cells tranfected with empty vector and untransfected Ishikawa cells(P<0.001).Interestingly,the expressions of PR-B mRNA and protein in overexpression EGFR Ishikawa cells were significantly decreased(P<0.001).(3)MPA treatment reduced the growth of parental Ishikawa cells and Ishikawa cells tranfected with empty vector in a dose-dependent manner:when MPA added at 10-7,10-6,10-5mol/L,the inhibitory effects were significantly respectively(P<0.05).But,the inhibitory effects in over-expression EGFR Ishikawa cells were not obvious(P>0.05).Conclusion:Transfection of EGFR can increase the expression of EGFR in Ishikawa cells,and decrease the sensitivity of MPA of human endometrial carcinoma cell line Ishikawa by reducing the expression of PR-B.
What problem does this paper attempt to address?